Amarin (ADR)
Commercializes icosapent ethyl for cardiovascular care through Vascepa and Vazkepa.
$13.97
After-hours close0.00 (0.00%)
At close$13.97(−0.71%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.10 | — | — |
| Jul 2026 | −$0.01 | −$0.02 | −100.0% |
| Apr 2026 | $0.01 | −$0.09 | −1,000.0% |
| Feb 2026 | $0.07 | $0.01 | −85.7% |
| Oct 2025 | $0.08 | $0.01 | −87.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.10 | — | — | $43.8M | — | — |
| Jul 29, 2026 | −$0.01 | −$0.02 | −100.0% | $44.6M | $42.2M | −5.3% |
| Apr 29, 2026 | $0.01 | −$0.09 | −1,000.0% | $43.8M | $45.1M | +3.1% |
| Feb 25, 2026 | $0.07 | $0.01 | −85.7% | $50.6M | $49.2M | −2.8% |
| Oct 29, 2025 | $0.08 | $0.01 | −87.5% | $43.1M | $49.7M | +15.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 30, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 12, 2025 | ||||||
| Oct 30, 2024 | ||||||
| Jul 31, 2024 | ||||||
| May 1, 2024 | ||||||
| Feb 29, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 3, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 3, 2023 | ||||||
| Mar 1, 2023 | ||||||
| Oct 27, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 4, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 5, 2021 | ||||||
| Apr 29, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 4, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 5, 2019 | ||||||
| Jul 31, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 1, 2018 | ||||||
| May 2, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 3, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 4, 2015 | ||||||